JINLI WU: Open Payments
NPI 1679022180 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,757 in 47 payments from 12 companies in 2025. Trend: 2023 $24 · 2024 $2,032 · 2025 $1,757
Food & beverage: $1,717Entertainment: $40
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 7 | $605 |
| ABBVIE INC. | 14 | $537 |
| Galderma Laboratories, L.P. | 10 | $274 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $111 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $71 |
| GENZYME CORPORATION | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Organon LLC | 3 | $19 |
Products named: DAXXIFY, BOTOX, DYSPORT, DUPIXENT, SKYRIZI, Winlevi, Sotyktu, VTAMA.
Industry payments across CA — which companies pay providers there.
